drugset / Trial / NCT03430531

Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

NCT03430531

Phase 2 Terminated 6 enrolled Milton S. Hershey Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The objective of the study is to determine the effectiveness of Spheno-Palatine (SP) ganglion block to alleviate the pain of post-dural puncture headache (PDPH).

Timeline

Start
2019-05-31
Primary completion
2020-01-16
Completion
2022-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 0.5 ml Intranasal
Subject Lidocaine Other / unclassified 2 % Intranasal